Literature DB >> 8672984

Genetic and cellular changes in colorectal cancer: proposed targets of chemopreventive agents.

P Greenwald1, G J Kelloff, C W Boone, S S McDonald.   

Abstract

Progress in development of a genetic model for colorectal tumorigenesis and human chemoprevention research may allow the mechanism-based identification of targets and chemopreventive agents that will protect against colorectal cancer. For example, numerous mutagenic events can occur throughout colorectal carcinogenesis, including loss of heterozygosity in tumor suppressor genes such as APC, MCC, DCC, and p53, as well as in oncogenes such as K-ras. Chemopreventive agents that inhibit mutagenic activity such as N-acetyl-l-cysteine, oltipraz, and nonsteroidal anti-inflammatory drugs may protect against these mutations. Also, agents such as perillyl alcohol and lovastatin that interfere with protein isoprenylation and, hence, inhibit oncogene activation may protect against aberrant K-ras expression. Hyperproliferation in normal mucosa, leading to growth and progression of neoplasia, are also aspects of colorectal carcinogenesis that can be controlled by chemopreventive agents. Calcium is a chemopreventive agent for which there is both clinical and experimental evidence of inhibition of cell proliferation in colon mucosa. Other examples of antiproliferative agents with potential chemopreventive efficacy in colon are 2-difluoromethylornithine, dehydroepiandrosterone, and selenium. Differentiating agents such as retinoids and deltanoids also may slow proliferation and progression. Antioxidants have potential for interfering with both mutagenicity and proliferation (e.g., by preventing oxidative activation of carcinogens and scavenging activated oxygen species generated during inflammation). The same mechanistic principles apply to identification of dietary chemopreventive intervention for colorectal carcinogenesis. For example, lowering dietary fat and increasing dietary fiber lead to lower colorectal mucosal proliferation, and cruciferous vegetables contain agents such as indoles and dithiolthiones that have shown antimutagenic activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8672984

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  6 in total

1.  Olive oil prevents benzo(a)pyrene [B(a)P]-induced colon carcinogenesis through altered B(a)P metabolism and decreased oxidative damage in Apc(Min) mouse model.

Authors:  Leah D Banks; Priscilla Amoah; Mohammad S Niaz; Mary K Washington; Samuel E Adunyah; Aramandla Ramesh
Journal:  J Nutr Biochem       Date:  2015-10-22       Impact factor: 6.048

2.  Glycine- and proline-rich glycoprotein regulates the balance between cell proliferation and apoptosis for ACF formation in 1,2-dimethylhydrazine-treated A/J mice.

Authors:  Sei-Jung Lee; Kye-Taek Lim
Journal:  Mol Cell Biochem       Date:  2009-01-31       Impact factor: 3.396

Review 3.  Cancer chemoprevention by citrus pulp and juices containing high amounts of β-cryptoxanthin and hesperidin.

Authors:  Takuji Tanaka; Takahiro Tanaka; Mayu Tanaka; Toshiya Kuno
Journal:  J Biomed Biotechnol       Date:  2011-11-24

4.  Novel Marine Compounds: Anticancer or Genotoxic?

Authors:  Jamal M. Arif; Amal A. Al-Hazzani; Muhammed Kunhi; Fahad Al-Khodairy
Journal:  J Biomed Biotechnol       Date:  2004

5.  Clinical effects of Garcinia kola in knee osteoarthritis.

Authors:  Olayinka O Adegbehingbe; Saburi A Adesanya; Thomas O Idowu; Oluwakemi C Okimi; Oyesiku A Oyelami; Ezekiel O Iwalewa
Journal:  J Orthop Surg Res       Date:  2008-07-30       Impact factor: 2.359

6.  Chronic ethanol feeding promotes azoxymethane and dextran sulfate sodium-induced colonic tumorigenesis potentially by enhancing mucosal inflammation.

Authors:  Pradeep K Shukla; Kamaljit K Chaudhry; Hina Mir; Ruchika Gangwar; Nikki Yadav; Bhargavi Manda; Avtar S Meena; RadhaKrishna Rao
Journal:  BMC Cancer       Date:  2016-03-07       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.